검색
Can Fite Biopharma Ltd
CANF관심 목록에 추가
4.700USD
+1.730+58.25%
종가 07/01, 16:00（ET）시세는 15분 지연됩니다
41.02K시가총액
손실P/E TTM
자세한 내용은 Can Fite Biopharma Ltd 회사
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Can Fite Biopharma Ltd 정보
종목 코드 CANF
회사 이름Can Fite Biopharma Ltd
상장일Sep 22, 2005
CEOFishman (Pnina)
직원 수5
유형Depository Receipt
회계 연도 종료Sep 22
주소10 Bareket Street, Kiryat Matalon
도시PETAH TIKVA
증권 거래소NASDAQ OMX – NASDAQ Basic Amex
국가Israel
우편 번호49170
전화97239241114
웹사이트https://www.canfite.com/
종목 코드 CANF
상장일Sep 22, 2005
CEOFishman (Pnina)
Can Fite Biopharma Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Yoseph Borenstein
Mr. Yoseph Borenstein
Director
Director
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
자주 묻는 질문
Can Fite Biopharma Ltd의 상위 5대 주주는 누구인가요?
Can Fite Biopharma Ltd의 상위 5대 주주는 다음과 같습니다: Dr. Sari Fishman, Ph.D.
Can Fite Biopharma Ltd(CANF)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Can Fite Biopharma Ltd의 주식을 보유한 기관은 총 28곳이며, 이들이 보유한 주식의 총 가치는 약 32.13K로 전체 발행 주식의 1.50%를 차지합니다. 이는 2025Q4 대비 -81636.00 증가한 수치입니다.